Here's Why You Should Hold on to Abbott (ABT) Stock for Now [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
Within Diabetes care, Libre's solid sales trajectory is encouraging and should continue to sustain with several new growth opportunities. Strong potential in the Diagnostics space is highly promising as well. However, the company faces challenges from lower demand for COVID-19 testing, which is hurting growth, as well as adverse currency movements. In the past year, this Zacks Rank #3 (Hold) stock has declined 4.4% compared with a 0.6% fall of the industry and a 26.6% rise of the S&P 500 composite. This renowned provider of a diversified line of healthcare products has a market capitalization of $181.08 billion. Abbott's earnings surpassed estimates in three of the trailing four quarters and matched on one occasion, the average surprise being 2.4%. Let's delve deeper. Factors at Play Libre Drives Diabetes Care: Abbott's Diabetes Care business continued to benefit from the growing sales of its flagship, sensor-based continuous glucose monitoring system, FreeStyle Libre. In
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott must pay US$495-million in premature infant formula trial, jury finds [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Abbott Labs falls after jury awards plaintiff $95M in damages in baby formula case [Seeking Alpha]Seeking Alpha
- Abbott must pay $95 million in premature infant formula trial, jury finds [CNBC]CNBC
- Cardiac Prosthetic Devices Market size is set to grow by USD 5.07 billion from 2024-2028, Rising prevalence of cardiac disorders to boost the market growth, Technavio [Yahoo! Finance]Yahoo! Finance
- An ugly earnings report from a competitor is good news for Abbott Labs [CNBC]CNBC
ABT
Earnings
- 7/18/24 - Beat
ABT
Sec Filings
- 7/18/24 - Form 8-K
- 7/2/24 - Form 4
- 7/2/24 - Form 4
- ABT's page on the SEC website